Sunshine Biopharma (SBFM) Notes Payables (2016 - 2021)
Historic Notes Payables for Sunshine Biopharma (SBFM) over the last 8 years, with Q4 2021 value amounting to $1.9 million.
- Sunshine Biopharma's Notes Payables rose 13157.91% to $1.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was $1.9 million, marking a year-over-year increase of 13157.91%. This contributed to the annual value of $1.9 million for FY2021, which is 13157.91% up from last year.
- Sunshine Biopharma's Notes Payables amounted to $1.9 million in Q4 2021, which was up 13157.91% from $330000.0 recorded in Q3 2021.
- Sunshine Biopharma's Notes Payables' 5-year high stood at $1.9 million during Q4 2021, with a 5-year trough of $183889.0 in Q1 2017.
- In the last 5 years, Sunshine Biopharma's Notes Payables had a median value of $517217.5 in 2020 and averaged $579101.3.
- Examining YoY changes over the last 5 years, Sunshine Biopharma's Notes Payables showed a top increase of 25716.33% in 2017 and a maximum decrease of 7445.97% in 2017.
- Sunshine Biopharma's Notes Payables (Quarter) stood at $596577.0 in 2017, then fell by 29.65% to $419663.0 in 2018, then skyrocketed by 39.71% to $586307.0 in 2019, then surged by 39.94% to $820454.0 in 2020, then soared by 131.58% to $1.9 million in 2021.
- Its Notes Payables stands at $1.9 million for Q4 2021, versus $330000.0 for Q3 2021 and $330000.0 for Q2 2021.